Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Sutent (sunitinib malate) - Important Safety Information from Pfizer as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
08/12/2010
Problem Or Issue:
Important safety information communication from Pfizer on Osteonecrosis of the jaw in cancer patients treated with sunitinib (Sutent) and concomitant or previous use of biphosphonates.
Important Safety Information - Sutent (sunitinib malate)
« Back
Date Printed: 16/05/2024